Brazil Biochip Market Size & Outlook, 2024-2030
Related Markets
Brazil biochip market highlights
- The Brazil biochip market generated a revenue of USD 213.7 million in 2024 and is expected to reach USD 397.4 million by 2030.
- The Brazil market is expected to grow at a CAGR of 10.3% from 2025 to 2030.
- In terms of segment, dna chips was the largest revenue generating type in 2024.
- Lab-on-chip is the most lucrative type segment registering the fastest growth during the forecast period.
Biochip market data book summary
| Market revenue in 2024 | USD 213.7 million |
| Market revenue in 2030 | USD 397.4 million |
| Growth rate | 10.3% (CAGR from 2025 to 2030) |
| Largest segment | Dna chips |
| Fastest growing segment | Lab-on-chip |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | DNA Chips, Protein Chips, Lab-on-chip, Tissue Arrays, Cell Arrays |
| Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.6% of the global biochip market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil biochip market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 397.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biochip Market Scope
Biochip Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil biochip market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 41.27% in 2024. Horizon Databook has segmented the Brazil biochip market based on dna chips, protein chips, lab-on-chip, tissue arrays, cell arrays covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of a large number of research institutes and laboratories that conduct genomic and cell related research is expected to drive the country’s market during the forecast period. Moreover, the high disease burden and supportive government legislation for research activities are contributing to regional market growth.
Moreover, various strategic initiatives undertaken by market players to strengthen precision medicine capabilities in the region are expected to support market growth. For instance, in May 2023, BGI Genomics collaborated with its partners in Latin America to strengthen its precision medicine capabilities in the region.
Reasons to subscribe to Brazil biochip market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil biochip market databook
-
Our clientele includes a mix of biochip market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil biochip market, including forecasts for subscribers. This country databook contains high-level insights into Brazil biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil biochips market size, by type, 2018-2030 (US$M)
Brazil Biochip Market Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
